Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot Study of EBV-TCR-T(YT-E001) in NPC Patients

Trial Profile

A Pilot Study of EBV-TCR-T(YT-E001) in NPC Patients

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Sep 2018

At a glance

  • Drugs EBV-TCR-T cell therapy (Primary) ; Cyclophosphamide; Fludarabine
  • Indications Nasopharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top